CiteIndex





1.
Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination.
Kappos L, Cohan S, Arnold DL, Robinson RR, Holman J, Fam S, Parks B, Xiao S, Castro-Borrero W.
Therapeutic advances in neurological disorders. 2021; 14(): 1756286420987941


Manuscript Analytics
DOI:
10.1177/1756286420987941

Click to reach Full-text


CiteIndex Statistics
Total View: 17
Total Download: 6
 
2
2
2
3
1
2
1
1
2
1
1
1
1
1
1
1
01-04-2021
02-04-2021
03-04-2021
04-04-2021
06-04-2021
07-04-2021
08-04-2021
09-04-2021
10-04-2021
11-04-2021
12-04-2021
14-04-2021
15-04-2021
Added to CiteIndex: Mar 31, 2021

Preview & Full-text of Manuscript
Altmetric Statistics

Dimentions Statistics
Plumx Statistics

Cited by these manuscripts

P A G E S

Home
Journals
Keywords

P A R T N E R S

ScopeMed
BiblioMed
eJManager

Privacy Policy | citeindex.org © 2021